Silo Pharma, Inc.
SILO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001514183
No open-market purchases or sales by Silo Pharma, Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $886.6K in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Silo Pharma, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 13 | 14 | +1 |
| Shares | 406.8K | 1.55M | +1.14M (+281.3%) |
| Value | $256.3K | $1.07M | +$813.5K (+317.4%) |
New holders (6)
Institutions that held Silo Pharma, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Anson Funds Management LP | 952,381 | $657.1K | 0.07% |
| Virtu Financial LLC | 107,786 | $74.0K | 0.00% |
| Jane Street Group, LLC | 16,772 | $11.6K | 0.00% |
| StoneX Group Inc. | 13,430 | $9.27K | 0.00% |
| UBS Group AG | 8,984 | $6.20K | 0.00% |
| Wells Fargo & Company | 10 | $7 | 0.00% |
Sold out (5)
Institutions that held Silo Pharma, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Ursa Fund Management, LLC | 37,500 | $23.6K |
| Citadel Advisors LLC | 28,160 | $17.7K |
| XTX Topco Ltd | 26,823 | $16.9K |
| Citigroup Inc | 10,866 | $6.85K |
| Federation des caisses Desjardins du Quebec | 6,000 | $3.78K |